The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry

American Heart Journal

Volumn 167, Issue 3, 2014, Pages

  Park, Kyung Woo ^b   Kang, Jeehoon ^b   Kang, Si Hyuck ^b   Ahn, Hyo Suk ^b   Kang, Hyun Jae ^b   Koo, Bon Kwon ^b   Chae, In Ho ^b   Youn, Tae Jin ^b   Oh, Byung Hee ^b   Park, Young Bae ^b   Kandzari, David ^b   Kim, Hyo Soo ^a  

^a Seoul National University   (South Korea)

^b PIEDMONT HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETIC PATIENT; DRUG ELUTING STENT; EVENT FREE SURVIVAL; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; REPEAT PROCEDURE; RESIDUAL CORONARY LESION; REVASCULARIZATION; SIROLIMUS ELUTING STENT; SURVIVAL RATE; SYNTAX SCORE;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TREATMENT OUTCOME;

EID: 84896699278     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.09.015     Document Type: Article

References (23)

1. P.A. Tonino, B. De Bruyne, and N.H. Pijls et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
2. G. Sianos, M.A. Morel, and A.P. Kappetein et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
3. S. Garg, G. Sarno, and C. Girasis et al. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials JACC Cardiovasc Interv 4 2011 645 653
4. S. Garg, P.W. Serruys, and S. Silber et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus-and everolimus-eluting stents: a substudy of the resolute all comers trial JACC Cardiovasc Interv 4 2011 432 441
5. Y.H. Kim, D.W. Park, and W.J. Kim et al. Validation of SYNTAX (synergy between pci with taxus and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization JACC Cardiovasc Interv 3 2010 612 623
6. P. Genereux, T. Palmerini, and A. Caixeta et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (synergy between PCI with taxus and cardiac surgery) score J Am Coll Cardiol 59 2012 2165 2174
7. S. Garg, G. Sarno, and H.M. Garcia-Garcia et al. A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score Circulation. Cardiovascular interventions. 3 2010 317 326
8. G.W. Stone, B.T. McLaurin, and D.A. Cox et al. Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
9. J.W. Chung, K.H. Park, and M.H. Lee et al. Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era Circ J 76 2012 1624 1630
10. D.N. Feldman, C.L. Gade, and A.J. Slotwiner et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry) Am J Cardiol 98 2006 1334 1339
11. J.A. Shaw, N. Andrianopoulos, and S. Duffy et al. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents Cardiovasc Revasc Med 9 2008 218 223
12. C. Girasis, S. Garg, and L. Raber et al. SYNTAX score and clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of sirolimus-eluting stent compared with paclitaxel-eluting stent for coronary revascularization (SIRTAX) trial Eur Heart J 32 2011 3115 3127
13. V. Farooq, P.W. Serruys, and H.M. Garcia-Garcia et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) trial J Am Coll Cardiol 61 2013 282 294
14. Z. Gao, B. Xu, and Y.J. Yang et al. Long-term outcomes of complete versus incomplete revascularization after drug-eluting stent implantation in patients with multivessel coronary disease Catheter Cardiovasc Interv 82 3 2013 343 349
15. J.J. Wykrzykowska, S. Garg, and C. Girasis et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter leaders (limus eluted from a durable versus erodable stent coating) trial J Am Coll Cardiol 56 2010 272 277
16. J.J. Wykrzykowska, S. Garg, and Y. Onuma et al. Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" leaders trial EuroIntervention 7 2011 605 613
17. G.F. Rosner, A.J. Kirtane, and P. Genereux et al. Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the acute catheterization and urgent intervention triage strategy (ACUITY) trial Circulation 125 2012 2613 2620
18. H. Shiomi, T. Tamura, and S. Niki et al. Inter-and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world Circ J 75 2011 1130 1137
19. P. Genereux, T. Palmerini, and A. Caixeta et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements Circ Cardiovasc Interv 4 2011 553 561
20. J.W. Sels, P.A. Tonino, and U. Siebert et al. Fractional flow reserve in unstable angina and non-st-segment elevation myocardial infarction experience from the FAME (fractional flow reserve versus angiography for multivessel evaluation) study JACC Cardiovasc Interv 4 2011 1183 1189
21. N.H. Pijls, W.F. Fearon, and P.A. Tonino et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (fractional flow reserve versus angiography for multivessel evaluation) study J Am Coll Cardiol 56 2010 177 184
22. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
23. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351